1. Home
  2. PEBK vs EMBC Comparison

PEBK vs EMBC Comparison

Compare PEBK & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Peoples Bancorp of North Carolina Inc.

PEBK

Peoples Bancorp of North Carolina Inc.

HOLD

Current Price

$43.96

Market Cap

218.4M

Sector

Finance

ML Signal

HOLD

Logo Embecta Corp.

EMBC

Embecta Corp.

HOLD

Current Price

$5.47

Market Cap

199.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEBK
EMBC
Founded
1912
1924
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.4M
199.9M
IPO Year
2012
2021

Fundamental Metrics

Financial Performance
Metric
PEBK
EMBC
Price
$43.96
$5.47
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$18.50
AVG Volume (30 Days)
39.7K
1.6M
Earning Date
04-20-2026
05-05-2026
Dividend Yield
2.58%
6.88%
EPS Growth
21.48
20.90
EPS
1.76
1.03
Revenue
N/A
N/A
Revenue This Year
N/A
$1.17
Revenue Next Year
N/A
N/A
P/E Ratio
$24.72
$5.26
Revenue Growth
N/A
N/A
52 Week Low
$27.33
$2.77
52 Week High
$45.78
$15.55

Technical Indicators

Market Signals
Indicator
PEBK
EMBC
Relative Strength Index (RSI) 54.43 77.85
Support Level $41.53 $3.01
Resistance Level $45.39 $9.38
Average True Range (ATR) 1.08 0.36
MACD 0.04 0.13
Stochastic Oscillator 57.45 95.17

Price Performance

Historical Comparison
PEBK
EMBC

About PEBK Peoples Bancorp of North Carolina Inc.

Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.

About EMBC Embecta Corp.

Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Share on Social Networks: